Medicare Advantage (MA) plans have been improperly denying many medical claims to both patients and physicians; low-income people in states that haven't expanded Medicaid are much more likely to forgo needed medical care, citing costs, than those in other states; dozens of vulnerable House Republicans have recently signed on to bills or resolutions in support of protecting pre-existing conditions.
Medicare Advantage (MA) plans have been improperly denying many medical claims to both patients and physicians, according to a report from the HHS inspector general. The New York Times reported that the report cited an incentive to deny claims in an effort to increase profits at the private insurers, which now cover more than one-third of all Medicare beneficiaries. The findings come as administration officials are creating new incentives to enroll in MA plans. Some experts predict that the share of Medicare patients in the private plans could grow to one-half in a few years.
Low-income people in states that haven't expanded Medicaid are much more likely to forgo needed medical care, citing costs, than those in other states, according to the Associated Press. The nonpartisan Government Accountability Office worked with the National Center for Health Statistics to analyze federal survey data from 2016. Nearly 20% of low-income people in nonexpansion states said they passed up needed care in the past 12 months, compared with 9.4% in states that expanded the program. Other findings noted that more people in nonexpansion states skipped prescribed medication or did not seek out specialist care compared with those in expansion states.
Dozens of vulnerable House Republicans have recently signed on to bills or resolutions in support of protecting pre-existing conditions. The Hill reported that the measures are more of an eleventh-hour political statement. They aren’t expected to pass or even get a markup at the committee level. Thirty-two of the 49 GOP incumbents in races deemed competitive by the nonpartisan Cook Political Report have backed congressional measures on pre-existing conditions in the past 6 weeks.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More